Risk factors

The company has shifted its strategy to hold massive amounts of SUI tokens as treasury assets, exposing itself to high crypto volatility. Over 88% of digital asset holdings are in SUI, creating extreme concentration risk and reliance on untested strategies.

Macro risks were reframed around global market disruption, tariffs and interest rates rather than recession, inflation and Brexit-specific uncertainty.

Teradata is aggressively transforming its business toward cloud, hybrid, and autonomous AI/ML offerings, facing execution risks, complex ERP stabilization, and competitive pressures for specialized talent.

Tenable added macroeconomic and geopolitical risks, expanded disclosures around reliance on third-party cloud vendors like AWS and Snowflake, and updated details on AI regulation and multi-year contract installment billing shifts.

Teleflex is executing a $2.0 billion strategic divestiture of its OEM, Acute Care, and Interventional Urology businesses.

TG Therapeutics added a specific risk regarding the development of a subcutaneous formulation of BRIUMVI. The company dropped risks covering broad market acceptance of BRIUMVI, third-party manufacturing reviews, and strategic resource allocation. Reworded risks updated details on tax capitalization rules for R&D and climate-related operational disruptions.

TransUnion added new specific risks regarding compliance with evolving global AI regulations and complex state data breach notification regimes. The company updated disclosures on its CFPB Consent Order, goodwill and intangible asset valuations, and climate change risk mitigation costs.

Trade Desk updated its risk disclosures to highlight emerging uncertainties around artificial intelligence adoption, evolving digital ad supply dynamics, and shifting macroeconomic trade policies.

The risk profile is dominated by the pending Blackstone Infrastructure merger and associated closing uncertainties and litigation.

Texas Roadhouse added new risks focusing heavily on brand reputation, ESG compliance pressures, and fast-moving social media campaigns. Consumer preference risks were updated to explicitly mention GLP-1 weight-loss drugs. International franchise regulations and specific IP litigation risks were removed.

The company added specific focus on fraud, AI and technology adoption, and fintech competitors. Vendor risk and competitive pressures were updated.

UFP Technologies expanded its risk disclosures with significant additions covering raw material forecasting, foreign currency exposure, and $135.5 million in debt. The company faces heightened risks regarding healthcare cost containment, international data protection regulations, and direct competition from suppliers.